Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-021730
Filing Date
2024-02-13
Accepted
2024-02-13 17:12:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tv01716-pmvpharmaceuticalsin.htm SC 13G/A 11462
  Complete submission text file 0001104659-24-021730.txt   12999
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

EIN.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address ONE RESEARCH WAY PRINCETON NJ 08540
Business Address ONE RESEARCH WAY PRINCETON NJ 08540 (609) 642-6664
PMV Pharmaceuticals, Inc. (Subject) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91714 | Film No.: 24629297
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)